Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy (Q43629454)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy |
scientific article |
Statements
1 reference
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy (English)
1 reference
N W Leung
1 reference
C L Lai
1 reference
T T Chang
1 reference
R Guan
1 reference
C M Lee
1 reference
K Y Ng
1 reference
S G Lim
1 reference
P C Wu
1 reference
J C Dent
1 reference
S Edmundson
1 reference
L D Condreay
1 reference
R N Chien
1 reference
Asia Hepatitis Lamivudine Study Group
1 reference
1 June 2001
1 reference
1 reference
Identifiers
1 reference